Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Motta

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Archives of Gerontology and Geriatrics|May 6, 2008
The metabolic syndrome (MS) in the elderly: considerations on the diagnostic criteria of the International Diabetes Federation (IDF) and some proposed modificationsMassimo Motta, Ettore Bennati, Elisabeth Cardillo, et al.
Archives of Gerontology and Geriatrics|September 22, 2009
Chromogranin A (CgA) serum level as a marker of progression in hepatocellular carcinoma (HCC) of elderly patientsMichele Malaguarnera, Marco Vacante, Rosangela Fichera, et al.
Archives of Gerontology and Geriatrics|August 15, 2008
The significance of apolipoprotein-B (Apo-B) in the elderly as a predictive factor of cardio-cerebrovascular complicationsMassimo Motta, Ettore Bennati, Elisabeth Cardillo, et al.
Archives of Gerontology and Geriatrics|November 11, 2005
The chromogranin-A (CgA) in prostate cancerSalvatore Ranno, Massimo Motta, Elvira Rampello, et al.
Archives of Gerontology and Geriatrics|October 5, 2007
A review on the actual trends of insulin treatment in elderly with diabetesMassimo Motta, Ettore Bennati, Laura Ferlito, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|December 17, 2011
Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinomaMario Uccello, Giulia Malaguarnera, Elisa M Pelligra, et al.
The American Journal of Clinical Nutrition|December 11, 2007
L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trialMariano Malaguarnera, Lisa Cammalleri, Maria Pia Gargante, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 22, 2004
Intravenous immunoglobulin plus interferon-alpha in autoimmune hepatitis CMariano Malaguarnera, Nicoletta Guccione, Salvatore Musumeci, et al.
Expert Opinion on Pharmacotherapy|April 9, 2009
A single dose of rasburicase in elderly patients with hyperuricaemia reduces serum uric acid levels and improves renal functionMariano Malaguarnera, Marco Vacante, Cristina Russo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 1, 2005
Efficacy of human recombinant erythropoietin plus IFN-alpha in patients affected by chronic hepatitis CIgnazio Di Fazio, Massimo Motta, Salvatore Musumeci, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Archives of Gerontology and Geriatrics|May 6, 2008
The metabolic syndrome (MS) in the elderly: considerations on the diagnostic criteria of the International Diabetes Federation (IDF) and some proposed modificationsMassimo Motta, Ettore Bennati, Elisabeth Cardillo, et al.
Archives of Gerontology and Geriatrics|September 22, 2009
Chromogranin A (CgA) serum level as a marker of progression in hepatocellular carcinoma (HCC) of elderly patientsMichele Malaguarnera, Marco Vacante, Rosangela Fichera, et al.
Archives of Gerontology and Geriatrics|August 15, 2008
The significance of apolipoprotein-B (Apo-B) in the elderly as a predictive factor of cardio-cerebrovascular complicationsMassimo Motta, Ettore Bennati, Elisabeth Cardillo, et al.
Archives of Gerontology and Geriatrics|November 11, 2005
The chromogranin-A (CgA) in prostate cancerSalvatore Ranno, Massimo Motta, Elvira Rampello, et al.
Archives of Gerontology and Geriatrics|October 5, 2007
A review on the actual trends of insulin treatment in elderly with diabetesMassimo Motta, Ettore Bennati, Laura Ferlito, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|December 17, 2011
Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinomaMario Uccello, Giulia Malaguarnera, Elisa M Pelligra, et al.
The American Journal of Clinical Nutrition|December 11, 2007
L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trialMariano Malaguarnera, Lisa Cammalleri, Maria Pia Gargante, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 22, 2004
Intravenous immunoglobulin plus interferon-alpha in autoimmune hepatitis CMariano Malaguarnera, Nicoletta Guccione, Salvatore Musumeci, et al.
Expert Opinion on Pharmacotherapy|April 9, 2009
A single dose of rasburicase in elderly patients with hyperuricaemia reduces serum uric acid levels and improves renal functionMariano Malaguarnera, Marco Vacante, Cristina Russo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 1, 2005
Efficacy of human recombinant erythropoietin plus IFN-alpha in patients affected by chronic hepatitis CIgnazio Di Fazio, Massimo Motta, Salvatore Musumeci, et al.
Pageof 5